Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
Clinical trial NCT02045654 · UNKNOWN
Trial details
- NCT number
- NCT02045654
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.